Development of a Predictive Model for Progressive Supranuclear Palsy Using Real World Data
Objective: To examine diagnoses and symptoms in progressive supranuclear palsy (PSP) patients in the 5 years before PSP diagnosis and to develop a model to…Association of metallic air pollution with Parkinson’s disease: a French nationwide incidence study
Objective: To determine whether atmospheric deposition of 6 metal trace elements - copper (Cu), iron (Fe), manganese (Mn), mercury (Hg), lead (Pb), and zinc (Zn)…Prevalence and clinical characteristics of Parkinson Disease in Chernivtsi Region of Ukraine
Objective: The aim of this study was to investigate prevalence and clinical characteristics of Parkinson’s disease (PD) in the Chernivtsi region of Ukraine among different…Gamma-glutamyltransferase and the risk of Parkinson’s disease: A National Health Service big data analysis
Objective: To evaluate the impact of serum gamma-glutamyltransferase (GGT) on the risk of Parkinson’s disease (PD). Background: Gamma-glutamyltransferase (GGT) majorly resides in the membrane of…Midbrain Atrophy in Patients with Preclinical Progressive Supranuclear Palsy
Objective: In the present study, midbrain atrophy and the pons-to-midbrain area ratio (P/M ratio) were investigated as diagnostic markers for preclinical progressive supranuclear palsy (Pre-PSP).…Peculiarities of the indicators of MR-diffusion in children’s cerebral palsy with symptomatic epilepsy
Objective: The purpose of the study was to determine the characteristics of the indicators of MR diffusion in children with symptomatic epilepsy with cerebral palsy.…Functional magnetic-resonant imaging in child cerebral palsy with epilepsy
Objective: the purpose of the study was to evaluate the possibilities of functional MRI in children with cerebral palsy in epilepsy. Background: Magnetic resonance spectroscopy…Relationship between serum uric acid and the pattern of striatal dopamine depletion in De Novo Parkinson’s disease
Objective: To investigate the relationship between serum uric acid (UA) and the pattern of striatal dopamine depletion in drug naïve Parkinson’s disease (PD). Background: UA…Incidental iron deposition in basal ganglia: does the pattern matter? Fifteen years’ experience in a tertiary care center.
Objective: We describe our series of patients with iron deposition in basal ganglia (IDBG) and hypothesize differences regarding the affected nuclei in patients with movement…Caudal posterior substantia nigra iron increases longitudinally in Parkinson’s disease
Objective: To investigate spatial patterns and temporal evolution of substantia nigra (SN) iron accumulation in Parkinson’s disease (PD) using quantitative susceptibility mapping (QSM), an indirect…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.